The global radiation therapy software market is predicted to reach US$ 354.9 million in 2022. Based on the report, sales of radiation therapy software are expected to grow at a CAGR of 8.20% to reach a market estimate of US$ 847.9 million by 2032.

Report Scope

Snapshot img

Radiation Oncology Market Size 2024-2028

The global radiation oncology market size is estimated to grow by USD 1.94 billion, at a CAGR of 4.34% between 2023 and 2028. The increasing incidence of cancer has spurred significant technological advances in radiation oncology, particularly in the development and adoption of advanced radiotherapy equipment. This trend reflects a global effort to enhance treatment efficacy and patient outcomes through precise targeting of tumors while minimizing damage to surrounding healthy tissue. Technological innovations such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT) have revolutionized cancer treatment, allowing for more tailored and effective therapies. The growing adoption of these sophisticated radiotherapy techniques underscores their importance in modern oncology practice, offering new hope and improved quality of life for cancer patients worldwide. As research continues to drive innovation, the future promises even more refined and personalized approaches to combating this complex disease.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Market Research Report Sample PDF

Market Segmentation

Type Analysis

The EBRT segment is estimated to witness significant growth during the forecast period. EBRT is usually delivered by X-rays, which are also called photons. It can also use electrons or other rare particles such as protons. EBRT is used to treat a wide range of diseases, such as breast tumor, CRC, esophageal tumor, head and neck tumor, lung tumor, prostate tumor, and brain tumor.

Get a glance at the market contribution of various segments Request Market Research Report Sample PDF

The EBRT segment was valued at USD 6.22 billion in 2018. EBRT delivers high-energy X-rays or beams that are generated outside the patient's body, generally by a LINAC, into the tumor. Moreover, Brachytherapy is an advanced tumor treatment procedure. It places sealed radioactive seeds or sources in or near the tumor to provide a high dose of radiation to the tumor and reduce radiation exposure in the surrounding healthy tissues. It is used to treat tumors such as the prostate, cervix, head and neck, skin, breast, gallbladder, uterus, vagina, lung, and rectum. Brachytherapy can be further segmented into seeds, applicators and after loaders, and electronic brachytherapy.

To know more about segments download the sample reports

Regional Analysis

Europe is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Market Research Report Sample PDF

Radiation oncology is a critical segment of oncology treatment that utilizes various devices and technologies to target and destroy abnormal cells. Key modalities include intracavitary brachytherapy using seeds and stereotactic therapy. Linear accelerators, such as X-ray machines and particle therapy systems, are essential radiation therapy equipment. These devices deliver precise doses of radiation to tumors, reducing pain and improving therapeutic benefits. Linear accelerators are used in the treatment of various cancers, including prostate, liver, lung, and neuroendocrine cancers. Metastatic melanoma and obesity pose unique challenges in radiation therapy, necessitating technological developments in radiotherapy equipment and treatment planning software. Regulatory scrutiny ensures the safety and efficacy of oncology devices, driving up the cost of healthcare spending.

In addition, physicians use radiotherapy devices, such as Linear accelerators and radioisotopes, in combination with radiopharmaceuticals and tumour tracking systems to provide effective oncology treatment. The rising healthcare spending and per-capita healthcare expenditure fuel the demand for advanced radiotherapy technology. Technological advancements in radiotherapy, such as proton therapy and targeted therapy, offer significant therapeutic benefits to patients. Provision Healthcare and other industry players invest in research and development to expand their product portfolios and cater to the evolving needs of the oncology market.

Key Players in Market

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Accuray Inc.- The company develops, manufactures, and markets proprietary medical devices used in radiation oncology therapy for the treatment of cancer patients. The key offerings of the company include radiation oncology solutions.

The market report also includes det

The Report Covers Global Radiotherapy Market Outlook & Share and it is Segmented by Type (External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy), Application (Skin & Lip Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Others), End User (Hospitals, Research Institutes and Ambulatory and Radiotherapy Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market size and forecasts are provided in terms of value (in USD) for the above segments.

Snapshot img

Radiation Therapy Equipment Market Size 2024-2028

The global radiation therapy equipment market size is estimated to grow by USD 1.59 billion, at a CAGR of 5.82% between 2023 and 2028.

With the global increase in cancer prevalence, governments in some countries are actively promoting awareness through cancer screening tests. Various organizations, such as the Union for International Cancer Control, which operates in over 100 countries, work at both global and national levels to enhance awareness about cancer prevention and management. The American Cancer Society and the Prevent Cancer Foundation have been raising awareness since 1913 and 1985, respectively. In developed countries, nationalized screening programs boost market growth. For instance, the UK’s National Health Service (NHS) aims to reduce cervical cancer cases through early detection and treatment. The NHS recommends cervical cancer screening for women aged 25 to 49 every three years. These efforts by governments and organizations enhance awareness about cancer prevention and management, contributing to market growth during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by End-user, Product and Geography Analysis

End-user Analysis

The hospitals segment is estimated to witness significant growth during the forecast period. Radiotherapy is an advanced technique used in the treatment of various conditions, such as cancer. This technology requires state-of-the-art equipment and infrastructure, making hospitals the primary end-users. Hospitals have the necessary resources to invest in high-tech radiotherapy devices. They often have dedicated oncology departments or cancer centers that specialize in providing these treatments. These departments use radiotherapy devices to precisely deliver radiation doses to cancerous tumors while minimizing damage to surrounding healthy tissues.

Get a glance at the market contribution of various segments Download PDF Sample

The hospitals segment was the largest and was valued at USD 2.21 billion in 2018. The adoption of radiotherapy devices in hospitals offers several benefits. These radiotherapy devices enhance treatment precision, reduce side effects, improve patient outcomes, and increase treatment efficiency. They also enable healthcare professionals to perform complex procedures with greater accuracy and safety. With the growing incidence of cancer worldwide, hospitals are increasingly investing in radiotherapy devices to provide comprehensive cancer care. Furthermore, advancements in technology and the introduction of new robotic platforms in radiotherapy devices are driving the adoption of these systems in hospitals, which will fuel the growth of the global radiation therapy equipment market through the hospitals segment during the forecast period.

Product Analysis

External beam radiation therapy equipment uses external beam radiation for treatment. Radiation beams used for treatment may consist of either photons, protons, or electrons. Most radiation therapy equipment uses photon beams. Photon beams can reach tumors present deep inside the body. However, while moving through the body, photon beams scatter in bits along their path, and after reaching the tumor site, they continue to pass through normal tissues, thereby damaging them in the process. Hence, protons, positive-charged particles, are preferred for use in radiation therapy equipment. Like photon beams, proton beams can also reach tumors located deep inside the body. However, they do not scatter radiation along their path and stop after reaching the tumor site. Electrons, negative-charged particles, cannot travel deep through body tissues. Hence, the use of electron beams is limited to tumors related to the skin or near the body surface. Moreover, the rise in the installation of external radiation therapy equipment by companies in hospitals and medical centers, along with a growing focus on precision radiation therapy from outside the body at the tumor, is expected to drive the growth of the external segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market has been experiencing an increasing number of product launches. For instance, in June 2021, Elekta received the FDA 510(k) Clearance for its Elekta Harmony radiation therapy system. In September 2020, the company launched Harmony Linear Accelerator (linac), a cancer treatment system specifically designed for healthcare centers. The region provides skill training pr

Radiation therapy in oncology market is expected to reach $9,206.6 million by the end of 2031. Radiation therapy in oncology market is expected to grow at a CAGR of 5.0% during the forecast period from 2021 to 2031.

The number of radiation therapy units in Italy declined to 432 radiation therapy units in 2021. Nevertheless, the last two years recorded a significant higher number of radiation therapy units than the preceding years.Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.Find more statistics on other topics about Italy with key insights such as number of physicians employed in hospitals and number of professional nurses and midwives employed in hospitals.

In 2021, the number of radiation therapy units in Finland did not change in comparison to the previous year. The number of radiation therapy units remained at 57 radiation therapy units. Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.

Report Overview

Global Radiation Oncology Market size is expected to be worth around USD 19.2 Billion by 2032 from USD 8.9 Billion in 2023, growing at a CAGR of 9.1% during the forecast period from 2023 to 2032.

Radiation oncology is the medical specialization troubled with suggesting radiation. Radiation oncology is usually applied to the cancerous tumor because of its ability to control cell growth. Radiation is used in medical imaging and identification.

Radiation might be recommended by a radiation oncologist in order for the treatment of adjuvant therapy. This process is used to treat cancer by radiating the tumor cells and destructing its growth and division procedure. Radiation oncology is also called radiation therapy. Radiation therapy might be beneficial in a numeral of types of cancer if they are controlled to one area of the body.

https://market.us/wp-content/uploads/2023/05/Radiation-Oncology-Market.jpg" alt="Radiation Oncology Market" width="1217" height="732">

Report Overview

The Global Radiotherapy Market size is expected to be worth around USD 12.1 Billion by 2033 from USD 6.8 Billion in 2023, growing at a CAGR of 5.9% during the forecast period from 2023 to 2032.

Radiotherapy is a cancer treatment that uses high doses of radiation to destroy cancer cells and shrink’s tumors. Radiotherapy is essential in cancer treatment and improves cancer patient survival rates. In addition, it is commonly used with other cancer treatments, such as surgery and chemotherapy. The market is increasing owing to the rising prevalence of cancer advances in technology and investment in cancer research.

https://market.us/wp-content/uploads/2023/10/Radiotherapy-Market-Growth.jpg" alt="Radiotherapy Market Growth" width="1216" height="709">

The Global Radiation Oncology Market Size Was Worth USD 6.6 Billion In 2019 And Is Expected To Register A CAGR Of 7.3% From 2020 To 2026.

In 2021, the number of radiation therapy units in Spain increased by 93 radiation therapy units (+36.61 percent) since 2020. Therefore, the number of radiation therapy units in Spain reached a peak in 2021 with 347 radiation therapy units. Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.Find more statistics on other topics about Spain with key insights such as number of health care assistants employed in hospitals and number of professional nurses and midwives employed in hospitals.

The number of radiation therapy units in France increased by 13 units (+1.71 percent) in 2021. With 775 units, the number of radiation therapy units thereby reached its highest value in the observed period. Radiation therapy equipment describes machines used for treatment with x-rays or radionuclide. By and large, this includes linear accelerators, Cobalt-60 units, Caesium-137 therapy units, low to orthovoltage x-ray units, high dose and low dose rate brachytherapy units and conventional brachytherapy units. Radiation therapy (or radiotherapy) is mostly used in the treatment of cancer, although it can also be used in the treatment of some rare, non-cancerous diseases.Find more statistics on other topics about France with key insights such as number of general practitioners employed in the health sector.

The study was conducted retrospectively at the Radiation Oncology, Steve Biko Academic Hospital. Data from 30 patients who underwent localised prostate cancer treatment were analysed, with a primary focus on the CBCT images obtained after applying treatment couch shifts to verify the treatment setup. These CBCT images were used to create new plans, which were then compared to reference plans based on the initial CT images. The 3-dimensional couch shift coordinates were evaluated against different absorbed dose constraints on the Planning Target Volume (PTV), specifically D2% (maximum absorbed dose) and D99%≥57 Gy (minimum absorbed dose). After applying couch shifts, the average results showed no significant difference between the planned and treated absorbed doses for D98% (F = 1.570, p = 0.201 > 0.05) and D2% (F = 1.841, p = 0.135 > 0.05). However, linear regression analysis revealed that inferior couch shifts significantly predicted D98% during treatment, while superior (SUP) couch shifts significantly predicted D2% during treatment. Notably, each unit of superior couch shift led to a 1.797 Gy decrease in D2% during treatment (t = -3.036, p < 0.05), with a negative beta value (β = -1.797). Despite these findings, the overall dose to the PTV did not significantly differ from the planning objectives. The differences in mean shifts and dosimetric plans/re-plans were compared using the ANOVA analysis.

Radiation Therapy Software Market Outlook

The global radiation therapy software market size is projected to grow from USD 1.7 billion in 2023 to an estimated USD 3.5 billion by 2032, reflecting a compound annual growth rate (CAGR) of approximately 8.3%. The primary growth factors driving this market include the increasing prevalence of cancer, advancements in radiation therapy technologies, and the rising demand for more precise and efficient cancer treatment solutions. Additionally, the integration of artificial intelligence and machine learning into radiation therapy software is expected to further propel market growth during the forecast period.

One of the key drivers of growth in the radiation therapy software market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with approximately 9.6 million deaths in 2018. This alarming statistic has led to an increased focus on improving cancer treatment methods, including radiation therapy. The need for more accurate and effective treatment planning and delivery has spurred the development and adoption of advanced radiation therapy software solutions. These systems enable healthcare providers to tailor treatment plans to individual patients, improving outcomes and reducing side effects.

Another significant growth factor is the continuous technological advancements in radiation therapy. Innovations such as image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT) have revolutionized the field of radiation oncology. These cutting-edge technologies require sophisticated software for treatment planning, dose management, and patient positioning. As a result, the demand for advanced radiation therapy software has surged, driving market growth. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in these software solutions is expected to enhance their capabilities, leading to more precise and efficient treatment planning and delivery.

The growing adoption of cloud-based solutions in the healthcare sector is another significant factor contributing to the market's expansion. Cloud-based radiation therapy software offers numerous advantages over traditional on-premises systems, including cost savings, scalability, and ease of access. These benefits have led to an increasing number of healthcare providers opting for cloud-based solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of telehealth and remote monitoring solutions, further boosting the demand for cloud-based radiation therapy software. This trend is expected to continue in the coming years, driving market growth.

Regionally, North America holds the largest share of the radiation therapy software market, followed by Europe and Asia Pacific. The high prevalence of cancer, advanced healthcare infrastructure, and significant investments in research and development contribute to the dominance of North America. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing healthcare expenditure, rising awareness about cancer treatment, and the growing adoption of advanced radiation therapy technologies. Emerging markets in Latin America and the Middle East & Africa are also expected to experience steady growth, supported by improving healthcare infrastructure and increasing focus on cancer treatment.

Product Type Analysis

The radiation therapy software market is segmented by product types, including Treatment Planning Systems, Dose Management Systems, Patient Positioning Systems, Image-Guided Radiation Therapy Systems, and Others. Each of these product types plays a crucial role in ensuring the precision and effectiveness of radiation therapy. Treatment Planning Systems are integral for devising customized treatment plans tailored to the specific needs of patients. This segment is expected to hold a significant market share, driven by the increasing demand for personalized treatment options and advancements in treatment planning algorithms. Additionally, the integration of AI and ML in treatment planning systems is anticipated to enhance their accuracy and efficiency, further propelling market growth.

Dose Management Systems are another critical component of radiation therapy software, ensuring that the prescribed dose of radiation is accurately delivered to the target area while minimizing exposure to surrounding healthy tissues. This segment is expected to witness substanti

The global radiotherapy market size was valued at USD 6.6 Billion in 2022 and is likely to reach USD 11.9 Billion by 2031, expanding at a CAGR of 6.4% during the forecast period, 2023–2031. Rising awareness of the benefits of radiotherapy is anticipated to boost the market in the coming years.



Radiotherapy is also known as radiation therapy and its operation is called radiation oncology. It is an integral part of modern cancer treatment and diagnosis. It is used to cure cancer by destroying cancer cells and minimizing the tumor size. Radiation therapy includes internal radiation therapy and external beam radiation.

In external beam radiation therapy, the radiation is emitted from a machine or a small container of radioactive material and is placed directly into or near the tumor. Whereas, internal radiotherapy directly delivers radiation from inside the body to cancer tumors, affecting a few healthy cells.

• In November 2021, the FDA gave a nod to DoseRT, an improved multi-camera system by Vision RT Ltd. as it monitors patient positioning and beam in real-time during radiotherapy.

• In December 2020, FDA approved a single-camera system, Beam Site by Dartmouth and Norris Cotton Cancer Center. It takes real-time video and images of the beam and helps in the treatment.

Over the last few years, the demand for radiotherapy increased due to the rising geriatric population with cancer, the increasing prevalence of cancer, and the growing adoption of radiotherapy devices. In 2020, as per the report of the National Cancer Institute, approximately 1,806,590 new cancer cases were diagnosed in the United States, and around 606,520 people died owing to cancer. The male population is commonly diagnosed with lung, prostate, and colorectal cancers, whereas, lung, breast, and colorectal cancer is found in females.



The research report finds that the COVID-19 pandemic adversely affected the radiotherapy market. The demand for radiotherapy was reduced due to the decrease in the number of general diagnoses and treatments conducted during the lockdown. For instance, In April 2020, according to the study results, average weekly radiotherapy courses dropped by 19.9%, 6·2% in May, and 11·6% in June.

Radiotherapy Market Dynamics